Gilead tops table for antivirals - Pharma TimesGilead tops table for antiviralsPharma TimesWith combined sales from the top HIV treatment on the market, Atripla, and several other drugs, Gilead Sciences leads the antiviral market, closely followed by Bristol-Myers Squibb, Roche and Merck & Co